Literature DB >> 29326077

Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?

János Szebeni1.   

Abstract

A recent study on nanoparticle-induced hypersensitivity reactions in pigs showed robust pulmonary intravascular macrophage clearance of Polybead® carboxylate microspheres in mediating the adverse cardiopulmonary distress, irrespective of the ability of these particles to activate the complement (C) system in vitro. Focusing on this observation, this article highlights the controversies in projecting in vitro C assay data to in vivo conditions and applying data on polystyrene particles to therapeutic nanopharmaceuticals. Based on overwhelming evidence of a role of anaphylatoxins in hypersensitivity reactions, the need to further explore the role of C activation in the reported and other reactions is highlighted. C-activation-related and C-independent pseudoallergies (CARPA and CIPA) can proceed simultaneously, as outlined by the 'double-hit' hypothesis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29326077     DOI: 10.1016/j.drudis.2018.01.025

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  14 in total

1.  The Relevance of Physico-Chemical Properties and Protein Corona for Evaluation of Nanoparticles Immunotoxicity-In Vitro Correlation Analysis on THP-1 Macrophages.

Authors:  Mojca Pavlin; Jasna Lojk; Klemen Strojan; Iva Hafner-Bratkovič; Roman Jerala; Adrijana Leonardi; Igor Križaj; Nataša Drnovšek; Saša Novak; Peter Veranič; Vladimir Boštjan Bregar
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

2.  Development of a Sensitive Assay to Screen Nanoparticles in vitro for Complement Activation.

Authors:  Nuzhat Maisha; Tobias Coombs; Erin Lavik
Journal:  ACS Biomater Sci Eng       Date:  2020-07-06

Review 3.  Lipid nanoparticle technology for therapeutic gene regulation in the liver.

Authors:  Dominik Witzigmann; Jayesh A Kulkarni; Jerry Leung; Sam Chen; Pieter R Cullis; Roy van der Meel
Journal:  Adv Drug Deliv Rev       Date:  2020-07-02       Impact factor: 15.470

Review 4.  Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions.

Authors:  János Szebeni; Raj Bawa
Journal:  Biomedicines       Date:  2020-04-08

5.  Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.

Authors:  László Dézsi; Tamás Mészáros; Erik Őrfi; Tamás G Fülöp; Mark Hennies; László Rosivall; Péter Hamar; János Szebeni; Gábor Szénási
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

6.  Effects of metal nanoparticles on tight junction-associated proteins via HIF-1α/miR-29b/MMPs pathway in human epidermal keratinocytes.

Authors:  Jiali Yuan; Yue Zhang; Yuanbao Zhang; Yiqun Mo; Qunwei Zhang
Journal:  Part Fibre Toxicol       Date:  2021-03-19       Impact factor: 9.400

7.  Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization.

Authors:  Tamás Mészáros; Gergely Tibor Kozma; Taro Shimizu; Koga Miyahara; Keren Turjeman; Tatsuhiro Ishida; Yechezkel Barenholz; Rudolf Urbanics; János Szebeni
Journal:  Int J Nanomedicine       Date:  2018-10-11

8.  Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro.

Authors:  Barry W Neun; Yechezkel Barenholz; Janos Szebeni; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2018-07-12       Impact factor: 4.411

Review 9.  Roadmap and strategy for overcoming infusion reactions to nanomedicines.

Authors:  Janos Szebeni; Dmitri Simberg; África González-Fernández; Yechezkel Barenholz; Marina A Dobrovolskaia
Journal:  Nat Nanotechnol       Date:  2018-10-22       Impact factor: 39.213

Review 10.  The Critical Choice of Animal Models in Nanomedicine Safety Assessment: A Lesson Learned From Hemoglobin-Based Oxygen Carriers.

Authors:  Peter Bedőcs; János Szebeni
Journal:  Front Immunol       Date:  2020-10-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.